Metrics & Benchmarks

>

Latest News

Credit: Sebastian Kaulitzki | stock.adobe.com. Full BATURA Results Highlight Efficacy of Albuterol/Budesonide Rescue Therapy
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma

May 20th 2025

Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.

Credit: Johannes | stock.adobe.com. View of cancerous squamous cell carcinoma in the esophagus through a microscope. Concept Medical Imaging, Cancer Research, Squamous Cell Carcinoma, Esophageal Diseases
Merck and Daiichi Sankyo Launch Global Phase III Trial of Novel Antibody Drug Conjugate in Advanced Esophageal Squamous Cell Carcinoma

May 19th 2025

Credit: MohammedElAmine | stock.adobe.com
KEYNOTE-B96 Trial Shows Keytruda is First Immunotherapy to Improve Overall Survival in Platinum-Resistant Ovarian Cancer

May 15th 2025

Credit: Juan Gärtner | stock.adobe.com
iTeos and GSK Halt TIGIT Antibody Belrestotug Development After Phase II Trials Miss Efficacy Marks in NSCLC and HNSCC

May 14th 2025

Credit: David A Litman | stock.adobe.com
APHINITY Trial Shows Perjeta-Based Regimen Improves 10-Year Overall Survival in HER2-Positive Early Breast Cancer

May 13th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.